Info
| ID | 606 |
| Metal | Ru |
| Oxidation state | 2 |
| Charge | 2 |
| Donor atoms | {"N": 8} |
| Abbreviation | Ru6S |
| SMILES | CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.c1cnc2c(c1)ccc1cccnc12.c1cnc2c(c1)ccc1cccnc12 |
TUCAN
C45H32ClF3N8O3Ru/(1-60)(2-34)(3-44)(4-36)(5-38)(6-37)(7-41)(8-61)(9-33)(10-39)(11-45)(12-62)(13-46)(14-63)(15-35)(16-48)(17-40)(18-64)(19-59)(20-47)(21-43)(22-51)(23-42)(24-50)(25-52)(26-59)(27-59)(28-53)(29-49)(30-79)(31-80)(32-78)(33-36)(33-60)(34-37)(34-54)(35-39)(35-61)(36-54)(37-55)(38-40)(38-55)(39-56)(40-63)(41-62)(41-72)(42-43)(42-67)(43-77)(44-46)(44-73)(45-49)(45-56)(46-70)(47-52)(47-70)(48-57)(48-67)(49-58)(50-51)(50-58)(51-64)(52-73)(53-71)(53-72)(54-65)(55-66)(56-68)(57-76)(57-77)(58-69)(59-80)(60-81)(61-82)(62-83)(63-84)(64-85)(65-66)(65-81)(66-84)(67-78)(68-69)(68-82)(69-85)(70-79)(71-74)(71-83)(72-88)(73-88)(74-80)(74-87)(75-78)(75-79)(75-86)(76-89)(76-90)(76-91)(77-92)(81-93)(82-93)(83-93)(84-93)(85-93)(88-93)
Measurements (6)
| Cell line | IC₅₀ dark (µM) | IC₅₀ light (µM) | DOI | Year |
| Caco-2 | 12 | — | 10.1021/acs.jmedchem.3c01115 | 2024 |
| MCF-7 | 19 | — | 10.1021/acs.jmedchem.3c01115 | 2024 |
| HT-29 | 42 | — | 10.1021/acs.jmedchem.3c01115 | 2024 |
| HepG2 | 55 | — | 10.1021/acs.jmedchem.3c01115 | 2024 |
| A549 | 65 | — | 10.1021/acs.jmedchem.3c01115 | 2024 |
| HEK293T | 66 | — | 10.1021/acs.jmedchem.3c01115 | 2024 |
🧬 Cell Death Types (1)
Apoptosis
high
«According to the apoptosis results, Ru3S decreased the live cell percentage at all concentrations (p < 0.01) and increased the rate of early apoptotic cells at 3.12 and 12.5 μM concentrations (p < 0.0...»
Source-assisted 2D generator
Builds the drawing from source ligand graphs and explicit donor metadata, then uses Metal2D only for layout. Publication output uses black bonds without arrows or colour highlighting; validated octahedral enantiomers are encoded directly with solid and hashed wedge bonds.
Loading source metadata…
The generated SVG will appear here. The legacy ligand image above stays visible for side-by-side review.